Sunday, 22 November 2026 Every SEC filing alert, by company
ALFAFINDER USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

BioNexus Gene Lab Q3 2026 Results: Net Loss of $1.05M, Loss Widens

BioNexus Gene Lab Corp. reported a significant revenue decline to $146,915 for the nine months ended September 30, 2026, compared to $6,941,151 in the prior year period. The company incurred a net loss of $1,884,406 during this period, driven by decreased gross profit and substantial share-based compensation expenses of $799,998.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue0.02.5
Gross profit0.00.4
Profit before tax-1.1-0.7
Net income-1.1-0.7
EPS (diluted, $ a share)$-0.39$-0.40

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year-98.1%
Gross margin9.4%
Source

10-Q filed with the SEC, NASDAQ: BGLC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

BioNexus Gene Lab Corp: key numbers

Share price
$0.6800Close, Nov 20
Market cap
$2.34M
Shares outstanding
3.49MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Medical LaboratoriesSIC 8071

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from BioNexus Gene Lab Corp

All →
9:01 AM ET 8-K
Licensing Deal

BioNexus Gene Lab Licensing Deal with Ruanyun Edai Technology Inc. Worth $3.5M

BioNexus Gene Lab Corp. entered into an exclusive 10-year licensing agreement with Ruanyun Edai Technology Inc. (RYET) for the CogniAI document-intelligence platform in the Malaysian healthcare sector. The company will issue 410,000 shares to satisfy the $3.5 million license consideration and an additional 150,000 shares in exchange for 500,000 RYET ordinary shares. BioNexus intends to use the platform to target Malaysia's RM1 billion public healthcare digitalization program.

Value
$3.5M
Counterparty
Ruanyun Edai Technology Inc.
Term
10 years

Get Alerts

Get ALFAFINDER USA alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.